Education
About Us
Working with TipRanks
Follow Us
Thyrocare Technologies Ltd (IN:THYROCARE)
:THYROCARE
Total Valuation
Thyrocare Technologies Ltd has a market cap or net worth of ₹71.31B. The enterprise value is ₹34.38B.
Market Cap₹71.31B
Enterprise Value₹34.38B
Share Statistics
Thyrocare Technologies Ltd has 52,994,446 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding52,994,446
Owned by Insiders―
Owned by Institutions0.25%
Financial Efficiency
Thyrocare Technologies Ltd’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 14.37%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)14.37%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee4.06M
Profits Per Employee867.57K
Employee Count1,693
Asset Turnover0.99
Inventory Turnover2.62
Valuation Ratios
The current PE Ratio of Thyrocare Technologies Ltd is 67.0. Thyrocare Technologies Ltd’s PEG ratio is ―.
PE Ratio67.0
PS Ratio0.00
PB Ratio0.00
Price to Fair Value7.05
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Thyrocare Technologies Ltd had revenue of 6.87B and earned 915.10M in profits. Earnings per share was 17.28.
Revenue6.87B
Gross Profit4.96B
Operating Income1.35B
Pretax Income1.45B
Net Income915.10M
EBITDA2.05B
Earnings Per Share (EPS)17.28
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Thyrocare Technologies Ltd pays an annual dividend of ₹21, resulting in a dividend yield of 1.56%
Dividend Per Share₹21
Dividend Yield1.56%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change75.58%
50-Day Moving Average1.09K
200-Day Moving Average907.74
Relative Strength Index (RSI)70.59
Average Volume (3m)12.11K
Important Dates
Thyrocare Technologies Ltd upcoming earnings date is Oct 29, 2025, TBA (Confirmed).
Last Earnings DateJul 23, 2025
Next Earnings DateOct 29, 2025
Ex-Dividend DateJul 25, 2025
Financial Position
Thyrocare Technologies Ltd as a current ratio of 2.77, with Debt / Equity ratio of 4.51%
Current Ratio2.77
Quick Ratio2.17
Debt to Market Cap<0.01
Net Debt to EBITDA0.03
Interest Coverage Ratio44.30
Taxes
In the past 12 months, Thyrocare Technologies Ltd has paid 546.90M in taxes.
Income Tax546.90M
Effective Tax Rate0.38
Enterprise Valuation
Thyrocare Technologies Ltd EV to EBITDA ratio is 18.82, with an EV/FCF ratio of 26.38.
EV to Sales5.62
EV to EBITDA18.82
EV to Free Cash Flow26.38
EV to Operating Cash Flow20.19
Balance Sheet
Thyrocare Technologies Ltd has ₹1.93B in cash and marketable securities with ₹246.80M in debt, giving a net cash position of -₹1.68B billion.
Cash & Marketable Securities₹1.93B
Total Debt₹246.80M
Net Cash-₹1.68B
Net Cash Per Share-₹31.76
Tangible Book Value Per Share₹81.24
Margins
Gross margin is 61.67%, with operating margin of 19.66%, and net profit margin of 13.31%.
Gross Margin61.67%
Operating Margin19.66%
Pretax Margin21.16%
Net Profit Margin13.31%
EBITDA Margin29.85%
EBIT Margin21.60%
Analyst Forecast
The average price target for Thyrocare Technologies Ltd is ₹1,460.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹1,460.00
Price Target Upside8.44% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast21.82%
EPS Growth Forecast36.97%